T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy
Hajari Taheri, Fatemeh, Hassani, Mahmoud, Sharifzadeh, Zahra, Behdani, Mehdi, Arashkia, Arash, Abolhassani, MohsenLanguage:
english
Journal:
IUBMB Life
DOI:
10.1002/iub.2019
Date:
February, 2019
File:
PDF, 1.22 MB
english, 2019